These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7863934)

  • 1. Effect of dose and field strength on enhancement with paramagnetic contrast media.
    Lindsey RO; Yetkin FZ; Prost R; Haughton VM
    AJNR Am J Neuroradiol; 1994 Nov; 15(10):1849-52. PubMed ID: 7863934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.
    Chang KH; Ra DG; Han MH; Cha SH; Kim HD; Han MC
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1413-9; discussion 1420-3. PubMed ID: 7985558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR-appearance of the pituitary gland before and after resection of pituitary macroadenomas.
    Steiner E; Math G; Knosp E; Mostbeck G; Kramer J; Herold CJ
    Clin Radiol; 1994 Aug; 49(8):524-30. PubMed ID: 7955862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varied microcirculation of pituitary adenomas at rapid, dynamic, contrast-enhanced MR imaging.
    Finelli DA; Kaufman B
    Radiology; 1993 Oct; 189(1):205-10. PubMed ID: 8372195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative evaluation for intracranial recurrence of medulloblastoma: MR findings with gadopentetate dimeglumine.
    Meyers SP; Wildenhain S; Chess MA; Tarr RW
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1425-34. PubMed ID: 7985559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging of pituitary region lesions with gadodiamide injection.
    Hald JK; Skalpe IO; Bakke SJ; Nakstad PH
    Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose of contrast material in the MR imaging evaluation of central nervous system tumors.
    Yuh WT; Halloran JI; Mayr NA; Fisher DJ; Nguyen HD; Simonson TM
    J Magn Reson Imaging; 1994; 4(3):243-9. PubMed ID: 8061421
    [No Abstract]   [Full Text] [Related]  

  • 8. MR of intracranial tumors: combined use of gadolinium and magnetization transfer.
    Kurki T; Niemi P; Valtonen S
    AJNR Am J Neuroradiol; 1994 Oct; 15(9):1727-36. PubMed ID: 7847221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast enhancement of normal intervertebral disks: time and dose dependence.
    Ibrahim MA; Jesmanowicz A; Hyde JS; Estkowski L; Haughton VM
    AJNR Am J Neuroradiol; 1994 Mar; 15(3):419-23. PubMed ID: 8197936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal and abnormal pituitary glands: gadopentetate dimeglumine-enhanced MR imaging.
    Sakamoto Y; Takahashi M; Korogi Y; Bussaka H; Ushio Y
    Radiology; 1991 Feb; 178(2):441-5. PubMed ID: 1987606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
    Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
    AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadopentetate dimeglumine-enhanced MR in the diagnosis of the Tolosa-Hunt syndrome.
    Zournas C; Trakadas S; Kapaki E; Doris S; Gatzonis S; Gouliamos A; Papageorgiou C
    AJNR Am J Neuroradiol; 1995 Apr; 16(4 Suppl):942-4. PubMed ID: 7611080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients.
    Kuhn MJ; Hammer GM; Swenson LC; Youssef HT; Gleason TJ
    Comput Med Imaging Graph; 1994; 18(5):391-9. PubMed ID: 7954317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor dissemination.
    Rippe DJ; Boyko OB; Fuller GN; Friedman HS; Oakes WJ; Schold SC
    AJNR Am J Neuroradiol; 1990; 11(4):800-1. PubMed ID: 2114771
    [No Abstract]   [Full Text] [Related]  

  • 15. Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.
    Miki Y; Matsuo M; Nishizawa S; Kuroda Y; Keyaki A; Makita Y; Kawamura J
    Radiology; 1990 Oct; 177(1):35-8. PubMed ID: 2399335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gasserian ganglion: appearance on contrast-enhanced MR.
    Downs DM; Damiano TR; Rubinstein D
    AJNR Am J Neuroradiol; 1996 Feb; 17(2):237-41. PubMed ID: 8938292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cranial tissues: normal MR appearance after intravenous injection of Gd-DTPA.
    Kilgore DP; Breger RK; Daniels DL; Pojunas KW; Williams AL; Haughton VM
    Radiology; 1986 Sep; 160(3):757-61. PubMed ID: 3488563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium-DTPA and MR imaging of pituitary adenoma: a preliminary report.
    Davis PC; Hoffman JC; Malko JA; Tindall GT; Takei Y; Avruch L; Braun IF
    AJNR Am J Neuroradiol; 1987; 8(5):817-23. PubMed ID: 3118674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of macroadenomas.
    Mohammad-Zadeh L
    Radiol Technol; 1995; 67(1):29-36; quiz 37-8. PubMed ID: 7491407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
    Mihara F; Gupta KL; Righi AM
    Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.